All Type of News
Joint marketing between BMS and Green Cross for ‘Baraclude’
BMS Korea(President Hye-sun Park) will jointly sell ‘Baraclude,’ a chronic hepatitis B treatment, with Green Cross(President Eun-cheol Huh) in the domestic market. On the 11th, the two companies announced establishmen...
Supported by Samsung, a new era with MERS vaccine has begun
The International Vaccine Institute(IVI, Director General Jerome Kim) will hold the ‘2015 Sinil-IVI Global Vaccine Forum: International MERS-CoV Symposium’ at Novotel Ambassador Gangnam on the 10th. In order to develo...
Reason why domestic companies need to get involved in special biopharmaceutical distribution
Multinational distribution companies and international expression couriers, such as DHL Express, FedEx Healthcare Shipping Solutions and World Courier Clinical Trial Logistics, have aggressively been getting involved ...
Dong-A breaking through the patent wall of BaracludeLast July, Dong-A ST has rapidly launched ‘Baracle Tab,’ a generic of Baraclude which left a month to its patent expiration. Its strategy is to preoccupy the market by breaking ...
|
Approval of Sovaldi triggered active new drug competition
‘Sovaldi(sofosbuvir), a hepatitis C treatment, has been approved.
According to the industry concerned on the 11th, Gilead Sciences Korea’s Sovaldi has acquired approval from Ministry of Food and Drug Safety(MFDS) on ...
Pfizer’s labor and management oppose over ERPWhen it comes to the Pfizer Korea’s ERP(Early Retirement Program), its labor union and management have run parallel.
On the last 7th, the labor union started a tent sit-in stri...
|
MOHW’s 2016 budget proposal confirmed at KRW 55.6 trillion
The next year’s budget proposal of the Ministry of Health and Welfare(MOHW) was confirmed at KRW 55.6 trillion.
According to the MOHW, the size of the total expenditure for the budget and fund operation plan of the M...
At the first symposium, “This will be a chance of exchange with North Korea’s academia”
A symposium related to the North Korea’s pharmaceutical system, which has been delayed once due to the spread of MERS, will be held on the 18th next week. Contents of the symposium have also been improved by participa...
Expected large-scale lawsuits of pharmaceutical companies against KRW 200 billion drug price reduction
While the government has notified drug price reduction worth of KRW 207.7 billion from the 1st of March next year, pharmaceutical companies with large cuts have considered lawsuits against the reduction. As a number o...
‘Lively’ OTC market from a series of product launches
A series of OTC drug launches have been made in the pharmaceutical industry. The OTC market has finally been active.
First, movements of Daewon Pharm, which entered the OTC market in 10 years, have attracted attentio...
